TKI

tyrosine kinase inhibitor

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TKI, covering 2021-11-26 to 2023-09-29. Get the full timeline:

Most recent: Clinical Trial Update: Tislelizumab Plus TKI as Adjuvant Therapy Versus Active Surveillance in Patients With HCC [Phase 2]